Research and Markets: Ovarian Cancer - Pipeline Review, Q3 2011

DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/e7cb56/ovarian_cancer_p) has announced the addition of Global Markets Direct's new report "Ovarian Cancer - Pipeline Review, Q3 2011" to their offering.

“Ovarian Cancer - Pipeline Review, Q3 2011”

Global Markets Direct's, 'Ovarian Cancer - Pipeline Review, Q3 2011', provides an overview of the Ovarian Cancer therapeutic pipeline. This report provides information on the therapeutic development for Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ovarian Cancer. 'Ovarian Cancer - Pipeline Review, Q3 2011' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope:

A snapshot of the global therapeutic scenario for Ovarian Cancer.
A review of the Ovarian Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Coverage of products based on various stages of development ranging from discovery till registration stages.
A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Coverage of the Ovarian Cancer pipeline on the basis of therapeutic class, route of administration and molecule type.
Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
Key discontinued pipeline projects.
Latest news and deals relating to the products.

Key Topics Covered:

Introduction
Ovarian Cancer Overview
Therapeutics Development
Ovarian Cancer Therapeutics under Development by Companies
Ovarian Cancer Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Mid Clinical Stage Products
Early Clinical Stage Products
Discovery and Pre-Clinical Stage Products
Ovarian Cancer Therapeutics - Products under Development by Companies
Ovarian Cancer Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Ovarian Cancer Therapeutics Development
Ovarian Cancer - Therapeutics Assessment
Late Stage Drug Profiles
Ovarian Cancer Therapeutics - Drug Profile Updates
Ovarian Cancer Therapeutics - Discontinued Products
Appendix
Methodology
Contact Us
Disclaimer

For more information visit http://www.researchandmarkets.com/research/e7cb56/ovarian_cancer_p

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Recent Stories from Research and Markets

Research and Markets: 2012 Report on the $25 Billion US Home Furnishings Stores Industry Featuring Bed Bath & Beyond and Williams-Sonoma

May 28, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/kf7kjc/home_furnishings_s) has announced the addition of the "Home Furnishings Stores" report to t... more »
Research and Markets: The Vietnamese Defense Industry: Market Opportunities and Entry Strategies, Analyses and Forecasts to 2016

May 28, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/lhzh3b/the_vietnamese_def) has announced the addition of iCD Research's new report "The Vietnamese... more »
Research and Markets: Singapore - Key Statistics, Telecommunications Market, Regulatory and Infrastructure Overview - 2012

May 28, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/83zgw6/singapore_key_st) has announced the addition of the "Singapore - Key Statistics, Telecommun... more »